Verde Bio Holdings, Inc.
VBHI · OTC
4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.03 | 0.00 | -4.76 |
| FCF Yield | -133.62% | -71.35% | -206.91% | -0.02% |
| EV / EBITDA | -0.86 | -7.36 | 0.43 | -699.43 |
| Quality | ||||
| ROIC | -62.00% | -73.43% | -117.48% | 15.21% |
| Gross Margin | 43.18% | 17.83% | -3.43% | 0.00% |
| Cash Conversion Ratio | 0.49 | 0.34 | 0.21 | 0.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 167.25% | – | – | -100.00% |
| Free Cash Flow Growth | 86.83% | -114.27% | -1,693.04% | -985.37% |
| Safety | ||||
| Net Debt / EBITDA | -0.26 | 0.05 | 1.98 | -0.45 |
| Interest Coverage | -24.89 | 0.00 | -8.10 | -1.12 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -170.71 | -40.01 | -887.67 | 0.00 |